BILL & MELINDA GATES FOUNDATION
We are excited about GHDDI’s potential to drive innovation in global health research and development, and look forward to partnering with Tsinghua University on our continued work to address the world’s most pressing global health challenges.
Co-Chair of the Bill & Melinda Gates Foundation
The establishment of GHDDI is an important effort by Tsinghua University to advance pharmaceutical research and translational medicine. I hope this initiative will facilitate the reform of pharmaceutical R&D system in China and impact global health.
PRESIDENT OF TSINGHUA UNIVERSITY
- GHDDI Launches A Scientific Research Data and Information Sharing Platform to Support Collective Research on 2019-nCoV 2020/01/28
- GHDDI and Tsinghua SPS Join Forces to Provide Drug Discovery Capabilities and Resources to All Researchers Who Are Working on the Novel Coronavirus Treatment 2020/01/27
- Bill Gates Remarks on the 10th Anniversary of Partnership with China on Tuberculosis Control 2019/11/20
GHDDI aims to become a major biomedical research center of excellence with a broad focus on translational research - from the bench to the bedside. Scientists at GHDDI work across a wide range of diseases that disproportionately affect populations in the developing world, including but not limited to tuberculosis, malaria, helminth infections, diarrheal disease, etc.LEARN MORE